Información del producto
GSK621 is a small molecule that has been shown to activate the AMPK pathway, which is involved in cellular energy metabolism. GSK621 can induce autophagy and may have potential as an adjuvant therapy for cervical cancer. This drug also has anti-inflammatory properties, which may be due to its ability to inhibit toll-like receptor signaling and mitigate oxidative injury. GSK621 alters mitochondrial membrane potential and causes mitochondrial dysfunction by inhibiting the production of ATP synthase.
Propiedades químicas
Consulta técnica sobre: 3D-WDC60705 GSK621
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.